DAVID SAMUEL SOLOMON, RPH
Pharmacy at 13 Ave, Brooklyn, NY
License number
New York 32766
Category
Pharmacy
Type
Pharmacist
Address
Address
13Th Ave, Brooklyn, NY 11219
Phone
(718) 436-6088
(718) 648-2882
(718) 648-2882
Personal information
See more information about DAVID SAMUEL SOLOMON at radaris.comName
Address
Phone
46 Catlin Ave, Roosevelt, NY 11575
457 Rockaway Pkwy #2, Brooklyn, NY 11212
440 E 79Th St APT 1F, New York, NY 10075
4 Beaver Hollow Ln, Airmont, NY 10952
503 Ridgetop Ln, Brewster, NY 10509
Professional information
See more information about DAVID SAMUEL SOLOMON at trustoria.com
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Type I And/Or Type Ii Phosphodiesterases
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Type I And/Or Type Ii Phosphodiesterases
US Patent:
2005016, Jul 28, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/996314
Inventors:
David Geliebter - Franklin Lakes NJ, US
David Solomon - Brooklyn NY, US
David Solomon - Brooklyn NY, US
International Classification:
A61K045/00, A61K031/5415, A61K031/52, A61K031/517
US Classification:
424093700, 514263220, 514224200, 514266210, 514263400
Abstract:
The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts by specifically inhibiting Type I and/or Type II phosphodiesterases. The present invention also relates to compositions comprising a specific inhibitor of a Type I and/or Type II phosphodiesterase for use in the methods of the invention.
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Type Iii And/Or Type Iv Phosphodiesterases
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Type Iii And/Or Type Iv Phosphodiesterases
US Patent:
2005016, Aug 4, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/996315
Inventors:
David Geliebter - Franklin Lakes NJ, US
David Solomon - Brooklyn NY, US
David Solomon - Brooklyn NY, US
International Classification:
A61K045/00, A61K031/519, A61K031/517
US Classification:
424093700, 514252160, 514262100, 514408000, 514252170, 514266220
Abstract:
The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts by specifically inhibiting Type III and/or Type IV phosphodiesterases. The present invention also relates to compositions comprising a specific inhibitor of a Type III and/or Type IV phosphodiesterase for use in the methods of the invention.
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Tumor Necrosis Factor-Alpha
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Inhibitors Of Tumor Necrosis Factor-Alpha
US Patent:
2005020, Sep 15, 2005
Filed:
Feb 17, 2005
Appl. No.:
11/060615
Inventors:
David Geliebter - Franklin Lakes NJ, US
David Solomon - Brooklyn NY, US
David Solomon - Brooklyn NY, US
International Classification:
A61K045/00, A01N001/02
US Classification:
424093700, 514323000, 435001100
Abstract:
The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts by inhibiting TNF-α. The present invention also relates to compositions comprising an inhibitor of a TNF-α for use in the methods of the invention, which compositions are free of active TGF-β or does not contain active TGF-β in an amount greater than endogenous blood levels.